BNP Paribas Maintains Neutral on AbbVie, Raises Price Target to $247
BNP Paribas analyst Navann Ty maintains AbbVie (NYSE: ABBV ) with a Neutral and raises the price target from $218 to $247.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.